Randomized Trial of Sertraline Versus Venlafaxine XR in Major Depression: Efficacy and Discontinuation Symptoms

文拉法辛 耐受性 舍曲林 中止 医学 内科学 随机对照试验 人口 萧条(经济学) 心理学 麻醉 精神科 焦虑 不利影响 抗抑郁药 经济 宏观经济学 环境卫生
作者
Aytekin Sır,Russell Franco D’Souza,Şükrü Uğuz,Tom George,Simavi Vahip,Malcolm Hopwood,Andrew J. Martin,William Lam,Tal Burt
出处
期刊:The Journal of Clinical Psychiatry [Physicians Postgraduate Press, Inc.]
卷期号:66 (10): 1312-1320 被引量:152
标识
DOI:10.4088/jcp.v66n1015
摘要

BACKGROUND: The comparative efficacy of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) was recently debated. Meta-analyses, based mainly on fluoxetine comparator data, suggest that the SNRI venlafaxine has superior efficacy to SSRIs in treatment of major depression. OBJECTIVE: To compare quality of life (QOL), efficacy, safety, and tolerability associated with sertraline and venlafaxine extended release (XR) for treatment of DSM-IV major depression. METHOD: This was an 8-week, double-blind, randomized study of sertraline (50-150 mg/day) versus venlafaxine XR (75-225 mg/day), followed by a 2-week taper period. Subjects were recruited from 7 sites in Turkey and 6 sites in Australia between October 2002 and July 2003. The primary outcome measure was the Quality of Life Enjoyment and Satisfaction Questionnaire. Secondary outcome measures included measures of depression (including response and remission), anxiety, pain, safety (e.g., blood pressure), and tolerability (e.g., discontinuation symptoms). RESULTS: A total of 163 subjects received study treatment (women, 69%; mean age, 37.0 [SD = 12.9] years). No significant differences in QOL or efficacy were noted between treatments on the primary or secondary endpoints for the total study population or the anxious depression and severe depression subgroups. A priori analyses of symptoms associated with treatment discontinuation demonstrated no difference between treatment groups. However, in post hoc analyses, sertraline was associated with less burden of moderate to severe discontinuation symptoms. Venlafaxine XR was associated with a relative increase in mean blood pressure (supine diastolic blood pressure, -4.4 mm Hg difference at week 8/last observation carried forward). CONCLUSION: Sertraline and venlafaxine XR demonstrated comparable effects on QOL and efficacy in treatment of major depression, although sertraline may be associated with a lower symptom burden during treatment discontinuation and a reduced risk of blood pressure increase.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
焦小黑发布了新的文献求助10
刚刚
刚刚
xiaoluoluo完成签到,获得积分10
刚刚
斯文败类的应助被科研小白采纳,获得10
刚刚
终梦的应助被辛酸有很多种采纳,获得20
刚刚
fanfan发布了新的文献求助10
1秒前
chai完成签到,获得积分10
2秒前
zlll完成签到 ,获得积分10
2秒前
乐天完成签到 ,获得积分10
3秒前
大喜完成签到,获得积分10
3秒前
3秒前
水煮电吹风的应助被hsj采纳,获得10
4秒前
xsx1111完成签到,获得积分10
4秒前
cloud云完成签到,获得积分10
5秒前
5秒前
向大闹闹发布了新的文献求助10
6秒前
燕燕完成签到 ,获得积分10
6秒前
7秒前
哇哇大叫发布了新的文献求助10
7秒前
Tang发布了新的文献求助10
8秒前
hsj完成签到,获得积分10
8秒前
8秒前
serendipity完成签到,获得积分10
8秒前
8秒前
流苏发布了新的文献求助10
9秒前
搜集达人的应助被Yutong采纳,获得10
9秒前
10秒前
可可完成签到,获得积分10
10秒前
Erpan发布了新的文献求助10
10秒前
HaoruMeng完成签到,获得积分10
10秒前
打打的应助被zyy采纳,获得30
10秒前
hnu301发布了新的文献求助10
11秒前
eason楽完成签到,获得积分20
11秒前
11秒前
醋酸柠檬完成签到,获得积分10
12秒前
朴素小鸟胃完成签到,获得积分10
12秒前
13秒前
菠菜的应助被cloud云采纳,获得10
13秒前
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181940
求助须知:如何正确求助?哪些是违规求助? 9571697
关于积分的说明 21819181
捐赠科研通 7778330
什么是DOI,文献DOI怎么找? 3433556
关于科研通互助平台的介绍 2557767
邀请新用户注册赠送积分活动 2479621